CLINICAL_TRIALS trial_result · 2023-05-24

Clinical Trial Update: The Clinical Study of the Safety and Efficacy of Istaroxime in Treatment of Acute Decompensated Heart Failure [Phase 2]

Phase 2 clinical trial evaluating safety and efficacy of istaroxime in acute decompensated heart failure has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Windtree Therapeutics | Conditions: Acute Decompensated Heart Failure | Phase 2 | Status: COMPLETED | Results posted: 2023-05-24